Filing Details

Accession Number:
0000899243-22-036695
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-22 16:00:14
Reporting Period:
2022-11-08
Accepted Time:
2022-11-22 16:00:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492674 T2 Biosystems Inc. TTOO Surgical & Medical Instruments & Apparatus (3841) 204827488
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1892921 A. Brett Giffin 101 Hartwell Avenue
Lexington MA 02421
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-08 3,333 $0.00 3,545 No 4 M Direct
Common Stock Disposition 2022-11-10 1,292 $1.79 2,253 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2022-11-08 3,333 $0.00 3,333 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,667 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  2. The sale reported in this Form 4 was made in order to pay the tax liability arising from vesting and settlement of RSU's on November 8, 2022. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.
  3. On February 26, 2022 the reporting person was granted 10,000 RSU's that vest in three substantially equal installments on November 8, 2022, November 8, 2023, and October 1, 2024.